Literature DB >> 31175141

Symptomatic and Radiographic Manifestations of Kidney Stone Recurrence and Their Prediction by Risk Factors: A Prospective Cohort Study.

Matthew R D'Costa1, William E Haley2, Kristin C Mara3, Felicity T Enders3, Terri J Vrtiska4, Vernon M Pais5, Steven J Jacobsen6, Cynthia H McCollough4, John C Lieske1, Andrew D Rule7.   

Abstract

BACKGROUND: Meaningful interpretation of changes in radiographic kidney stone burden requires understanding how radiographic recurrence relates to symptomatic recurrence and how established risk factors predict these different manifestations of recurrence.
METHODS: We recruited first-time symptomatic stone formers from the general community in Minnesota and Florida. Baseline and 5-year follow-up study visits included computed tomography scans, surveys, and medical record review. We noted symptomatic recurrence detected by clinical care (through chart review) or self-report, and radiographic recurrence of any new stone, stone growth, or stone passage (comparing baseline and follow-up scans). To assess the prediction of different manifestations of recurrence, we used the Recurrence of Kidney Stone (ROKS) score, which sums multiple baseline risk factors.
RESULTS: Among 175 stone formers, 19% had symptomatic recurrence detected by clinical care and 25% detected by self-report; radiographic recurrence manifested as a new stone in 35%, stone growth in 24%, and stone passage in 27%. Among those with a baseline asymptomatic stone (54%), at 5 years, 51% had radiographic evidence of stone passage (accompanied by symptoms in only 52%). Imaging evidence of a new stone or stone passage more strongly associated with symptomatic recurrence detected by clinical care than by self-report. The ROKS score weakly predicted one manifestation-symptomatic recurrence resulting in clinical care (c-statistic, 0.63; 95% confidence interval, 0.52 to 0.73)-but strongly predicted any manifestation of symptomatic or radiographic recurrence (5-year rate, 67%; c-statistic, 0.79; 95% confidence interval, 0.72 to 0.86).
CONCLUSIONS: Recurrence after the first stone episode is both more common and more predictable when all manifestations of recurrence (symptomatic and radiographic) are considered.
Copyright © 2019 by the American Society of Nephrology.

Entities:  

Keywords:  Epidemiology and outcomes; clinical nephrology; kidney stones; outcomes; risk factors

Mesh:

Year:  2019        PMID: 31175141      PMCID: PMC6622409          DOI: 10.1681/ASN.2018121241

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  25 in total

1.  A prospective study of recurrence rate and risk factors for recurrence after a first renal stone.

Authors:  A Trinchieri; F Ostini; R Nespoli; F Rovera; E Montanari; G Zanetti
Journal:  J Urol       Date:  1999-07       Impact factor: 7.450

2.  Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT.

Authors:  Deirdre M Coll; Michael J Varanelli; Robert C Smith
Journal:  AJR Am J Roentgenol       Date:  2002-01       Impact factor: 3.959

3.  LONG-TERM SURVEY OF 538 PATIENTS WITH UPPER URINARY TRACT STONE.

Authors:  R E WILLIAMS
Journal:  Br J Urol       Date:  1963-12

Review 4.  Quantitation of stone burden: imaging advances.

Authors:  Terri J Vrtiska
Journal:  Urol Res       Date:  2005-11-13

5.  The natural history of renal and ureteric calculi.

Authors:  V Marshall; R H White; M C De Saintonge; G C Tresidder; J P Blandy
Journal:  Br J Urol       Date:  1975-04

6.  Radiological imaging of patients with suspected urinary tract stones: national trends, diagnoses, and predictors.

Authors:  Antonio C Westphalen; Renee Y Hsia; Judith H Maselli; Ralph Wang; Ralph Gonzales
Journal:  Acad Emerg Med       Date:  2011-07       Impact factor: 3.451

Review 7.  Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline.

Authors:  Howard A Fink; Timothy J Wilt; Keith E Eidman; Pranav S Garimella; Roderick MacDonald; Indulis R Rutks; Michelle Brasure; Robert L Kane; Jeannine Ouellette; Manoj Monga
Journal:  Ann Intern Med       Date:  2013-04-02       Impact factor: 25.391

8.  Progression of nephrolithiasis: long-term outcomes with observation of asymptomatic calculi.

Authors:  Abram Burgher; Mandi Beman; Jeremy L Holtzman; Manoj Monga
Journal:  J Endourol       Date:  2004-08       Impact factor: 2.942

9.  Natural history of asymptomatic renal stones and prediction of stone related events.

Authors:  Ho Won Kang; Sang Keun Lee; Won Tae Kim; Yong-June Kim; Seok-Joong Yun; Sang-Cheol Lee; Wun-Jae Kim
Journal:  J Urol       Date:  2012-11-28       Impact factor: 7.450

Review 10.  History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population.

Authors:  Walter A Rocca; Barbara P Yawn; Jennifer L St Sauver; Brandon R Grossardt; L Joseph Melton
Journal:  Mayo Clin Proc       Date:  2012-11-28       Impact factor: 7.616

View more
  11 in total

Review 1.  Randall's plaque and calcium oxalate stone formation: role for immunity and inflammation.

Authors:  Saeed R Khan; Benjamin K Canales; Paul R Dominguez-Gutierrez
Journal:  Nat Rev Nephrol       Date:  2021-01-29       Impact factor: 28.314

2.  iTRAQ-Based Comparative Proteomics Analysis of Urolithiasis Rats Induced by Ethylene Glycol.

Authors:  Yanan Cao; Bin Duan; Xiaowei Gao; E Wang; Zhitao Dong
Journal:  Biomed Res Int       Date:  2020-05-15       Impact factor: 3.411

3.  Study of risk factor of urinary calculi according to the association between stone composition with urine component.

Authors:  Pan Wang; Hongxian Zhang; Jiansuo Zhou; Shangjia Jin; Chong Liu; Boxin Yang; Liyan Cui
Journal:  Sci Rep       Date:  2021-04-22       Impact factor: 4.379

4.  Identification of the pivotal role of SPP1 in kidney stone disease based on multiple bioinformatics analysis.

Authors:  Sen-Yuan Hong; Qi-Dong Xia; Jin-Zhou Xu; Chen-Qian Liu; Jian-Xuan Sun; Yang Xun; Shao-Gang Wang
Journal:  BMC Med Genomics       Date:  2022-01-11       Impact factor: 3.063

5.  Clinical and Kidney Structural Characteristics of Living Kidney Donors With Nephrolithiasis and Their Long-term Outcomes.

Authors:  Matthew R D'Costa; Massini A Merzkani; Aleksandar Denic; Aidan F Mullan; Joseph J Larson; Walter K Kremers; Walter D Park; Mariam P Alexander; Harini A Chakkera; Sandra J Taler; Stephen J Erickson; Mark D Stegall; Naim Issa; Andrew D Rule
Journal:  Transplant Direct       Date:  2021-12-23

6.  Risk factors for kidney stone disease recurrence: a comprehensive meta-analysis.

Authors:  Kai Wang; Jing Ge; Wenlong Han; Dong Wang; Yinjuan Zhao; Yanhao Shen; Jiexun Chen; Dongming Chen; Jing Wu; Ning Shen; Shuai Zhu; Bin Xue; Xianlin Xu
Journal:  BMC Urol       Date:  2022-04-19       Impact factor: 2.090

7.  Development and validation of a nomogram for risk prediction of nephrolithiasis recurrence in patients with primary hyperparathyroidism.

Authors:  Yihong Zhou; Xi Chu; Dong Jiang; Xiang Wu; Jiarong Xu; Hao Qi; Yuxin Tang; Yingbo Dai
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-31       Impact factor: 6.055

8.  Clinician Versus Nomogram Predicted Estimates of Kidney Stone Recurrence Risk.

Authors:  Connor M Forbes; Allison B McCoy; Ryan S Hsi
Journal:  J Endourol       Date:  2020-11-16       Impact factor: 2.619

9.  Prediction of the occurrence of calcium oxalate kidney stones based on clinical and gut microbiota characteristics.

Authors:  Liyuan Xiang; Xi Jin; Yu Liu; Yucheng Ma; Zhongyu Jian; Zhitao Wei; Hong Li; Yi Li; Kunjie Wang
Journal:  World J Urol       Date:  2021-08-24       Impact factor: 4.226

10.  Outcomes and rates of dissolution therapy for uric acid stones.

Authors:  Jonathan Moore; Amihay Nevo; Saif Salih; Haidar Abdul-Muhsin; Mira Keddis; Karen Stern; Mitchell Humphreys
Journal:  J Nephrol       Date:  2021-06-25       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.